Proliferative Vitreoretinopathy: Pathobiology and Therapeutic Targets
- 1 January 2009
- journal article
- review article
- Published by Taylor & Francis in Seminars in Ophthalmology
- Vol. 24 (2) , 62-69
Abstract
The cell biology and molecular mediators of proliferative vitreoretinopathy continue to be elucidated. The purpose of this review is to summarize contemporary findings in the visual and neurosciences relevant to the pathophysiology of proliferative vitreoretinopathy, with an emphasis on the biologic mediators that represent potential therapeutic targets.Keywords
This publication has 72 references indexed in Scilit:
- Age-Related Macular DegenerationNew England Journal of Medicine, 2008
- CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failureExperimental Neurology, 2008
- Special issue: Spinal cord regeneration and repairExperimental Neurology, 2007
- Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosisProceedings of the National Academy of Sciences, 2007
- Tenascin-C Levels in the Vitreous of Patients with Proliferative VitreoretinopathyOphthalmologica, 2003
- Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC)Eye, 2002
- Photoreceptor-Specific Expression of Platelet-Derived Growth Factor-B Results in Traction Retinal DetachmentThe American Journal of Pathology, 2000
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- PROLIFERATIVE VITREORETINOPATHYRetina, 1988
- Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study.British Journal of Ophthalmology, 1984